Beverly Moy - Dissemin

Language
Login

All papers authored by Beverly Moy

This paper is made freely available by the publisher.

2023 Beverly Moy

ORCID

, Antonio C. Wolff

ORCID

, R. Bryan Rumble

ORCID

, Kimberly H. Allison, Lisa A. Carey

ORCID

Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2021 Beverly Moy

ORCID

, Mafalda Oliveira, Cristina Saura, William Gradishar, Sung-Bae Kim, Adam Brufsky, Sara A. Hurvitz, Larisa Ryvo, Daniele Fagnani, Sujith Kalmadi, Paula Silverman, Suzette Delaloge, Jesus Alarcon, Ava Kwong, Keun Seok Lee and 10 other authors

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Upload

Missing publications? Search for publications with a matching author name.